445472483	445472483	CD	B-NP	O
|	|	NN	I-NP	O
RMC	RMC	NN	I-NP	O
|	|	NN	I-NP	O
54049042	54049042	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
3687073	3687073	CD	B-NP	O
|	|	CC	I-NP	O
4/2/2006	4/2/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/28/2006	8/28/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
ATTENDING	ATTENDING	NN	B-NP	O
:	:	:	O	O
DELOGE	DELOGE	NN	B-NP	O
,	,	,	O	O
NOBLE	NOBLE	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
PRIMARY	PRIMARY	NNP	I-NP	O
CARE	CARE	NNP	I-NP	O
PHYSICIAN	PHYSICIAN	NNP	I-NP	O
:	:	:	O	O
Jason	Jason	NNP	B-NP	O
Kassing	Kassing	NNP	I-NP	O
,	,	,	O	O
NP	NP	NNP	B-NP	O
SERVICE	SERVICE	NNP	I-NP	O
:	:	:	O	O
WH	WH	NNP	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Shortness	Shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Buetti	Buetti	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
49-year-old	49-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
COPD	COPD	NN	B-NP	O
on	on	IN	B-PP	O
3	3	CD	B-NP	O
to	to	TO	I-NP	O
4	4	CD	I-NP	O
liters	liter	NNS	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
CABG	CABG	NN	I-NP	O
,	,	,	O	O
PE	PE	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
recent	recent	JJ	I-NP	O
admission	admission	NN	I-NP	O
for	for	IN	B-PP	O
cellulitis	cellulitis	NN	B-NP	O
complicated	complicate	VBN	B-VP	O
by	by	IN	B-PP	O
hypoxic	hypoxic	JJ	B-NP	O
respiratory	respiratory	JJ	I-NP	O
failure	failure	NN	I-NP	O
requiring	require	VBG	B-VP	O
intubation	intubation	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
recent	recent	JJ	B-NP	O
admission	admission	NN	I-NP	O
for	for	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	I-NP	O
fluid	fluid	NN	I-NP	O
overload	overload	NN	I-NP	O
complicated	complicate	VBN	B-VP	O
by	by	IN	B-PP	O
PE	PE	NN	B-NP	O
while	while	IN	B-SBAR	O
anticoagulated	anticoagulate	VBN	B-NP	O
leading	lead	VBG	I-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
pulseless	pulseless	JJ	I-NP	O
electrical	electrical	JJ	I-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
DHC	DHC	NN	B-NP	O
from	from	IN	B-PP	O
5/15/06	5/15/06	CD	B-NP	O
to	to	TO	B-PP	O
07	07	CD	B-NP	O
for	for	IN	B-PP	O
respiratory	respiratory	JJ	B-NP	O
distress	distress	NN	I-NP	O
again	again	RB	B-ADVP	O
with	with	IN	B-PP	O
fluid	fluid	NN	B-NP	O
overload	overload	NN	I-NP	O
requiring	require	VBG	B-VP	O
diuresis	diuresis	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
En	En	NNP	I-NP	O
General	General	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
complained	complain	VBD	B-VP	O
of	of	IN	B-PP	O
burning	burn	VBG	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
different	different	JJ	B-ADJP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
previous	previous	JJ	I-NP	O
cardiac	cardiac	JJ	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
notes	note	VBZ	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
feel	feel	VB	I-VP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

REVIEW	REVIEW	NNP	B-NP	O
OF	OF	IN	B-PP	O
SYSTEMS	SYSTEMS	NNP	B-NP	O
:	:	:	O	O
Positive	Positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
palpitations	palpitation	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
neck	neck	NN	I-NP	O
,	,	,	O	O
jaw	jaw	NN	B-NP	O
or	or	CC	O	O
back	back	RB	B-ADVP	O
pain	pain	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
nausea	nausea	NN	I-NP	O
or	or	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
dizziness	dizziness	NN	I-NP	O
,	,	,	O	O
positive	positive	JJ	B-NP	O
body	body	NN	I-NP	O
swelling	swelling	NN	I-NP	O
and	and	CC	O	O
positive	positive	JJ	B-NP	O
20-pound	20-pound	JJ	I-NP	O
weight	weight	NN	I-NP	O
gain	gain	NN	I-NP	O
over	over	IN	B-PP	O
one	one	CD	B-NP	O
month	month	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

BuSpar	BuSpar	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

Lasix	Lasix	NN	B-NP	O
120	120	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

Metazolone	Metazolone	NN	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
5	5	CD	I-NP	O
.	.	.	O	O

Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

Prozac	Prozac	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Methadone	Methadone	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Lopressor	Lopressor	NN	B-NP	O
12.5	12.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
9	9	CD	I-NP	O
.	.	.	O	O

Senna	Senna	NNP	B-NP	O
two	two	CD	I-NP	O
tablets	tablet	NNS	I-NP	O
p.o.	p.o.	FW	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

Verapamil	Verapamil	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
11	11	CD	I-NP	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
33	33	CD	I-NP	O
mg	mg	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Multivitamin	Multivitamin	NN	B-NP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Folate	Folate	NN	B-NP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Zocor	Zocor	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

K-Dur	K-Dur	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
16	16	CD	I-NP	O
.	.	.	O	O

OxyContin	OxyContin	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

17	17	CD	B-NP	O
.	.	.	O	O

Seroquel	Seroquel	NN	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

18	18	CD	B-NP	O
.	.	.	O	O

DuoNeb	DuoNeb	NNP	B-NP	O
p.r.n.	p.r.n.	IN	B-PP	O
19	19	CD	B-NP	O
.	.	.	O	O

Albuterol	Albuterol	NNP	B-NP	O
p.r.n.	p.r.n.	IN	B-PP	O
20	20	CD	B-NP	O
.	.	.	O	O

Protonix	Protonix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

21	21	CD	B-NP	O
.	.	.	O	O

Insulin	Insulin	NNP	B-NP	O
Aspart	Aspart	NNP	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Noncontributory	Noncontributory	JJ	B-ADJP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
homeless	homeless	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	O	O
occasionally	occasionally	RB	B-VP	O
lives	live	VBZ	I-VP	O
with	with	IN	B-PP	O
family	family	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
tobacco	tobacco	NN	I-NP	O
history	history	NN	I-NP	O
.	.	.	O	O

Positive	Positive	JJ	B-NP	O
ETOH	ETOH	NN	I-NP	O
.	.	.	O	O

Positive	Positive	JJ	B-NP	O
addiction	addiction	NN	I-NP	O
,	,	,	O	O
methadone	methadone	NN	B-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAM	EXAM	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Vital	Vital	JJ	B-NP	O
signs	sign	NNS	I-NP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-ADJP	O
,	,	,	O	O
irregularly	irregularly	RB	B-ADJP	O
irregular	irregular	JJ	I-ADJP	O
.	.	.	O	O

No	No	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	I-NP	O
gallops	gallop	NNS	I-NP	O
or	or	CC	I-NP	O
rubs	rub	NNS	I-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-NP	O
,	,	,	I-NP	O
bibasilar	bibasilar	JJ	I-NP	O
crackles	crackle	NNS	I-NP	O
and	and	CC	I-NP	O
wheezes	wheeze	NNS	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
,	,	,	O	O
firm	firm	NN	B-NP	O
,	,	,	O	O
distended	distend	VBN	B-VP	O
,	,	,	O	O
nontender	nontender	JJ	B-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
rebound	rebound	NN	I-NP	O
or	or	CC	I-NP	O
guarding	guarding	NN	I-NP	O
.	.	.	O	O

Lower	Low	JJR	B-NP	O
extremities	extremity	NNS	I-NP	O
,	,	,	O	O
edematous	edematous	JJ	B-ADJP	O
.	.	.	O	O

ASSESSMENT	ASSESSMENT	NN	B-NP	O
AND	AND	CC	I-NP	O
PLAN	PLAN	NN	I-NP	O
:	:	:	O	O
A1	A1	NN	B-NP	B-protein
49-year-old	49-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
COPD	COPD	NN	B-NP	O
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
CABG	CABG	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
PE	PE	NN	I-NP	O
with	with	IN	B-PP	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
complicated	complicate	VBN	B-VP	O
by	by	IN	B-PP	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
hyperkalemia	hyperkalemia	NN	B-NP	O
and	and	CC	I-NP	O
UTI	UTI	NN	I-NP	O
.	.	.	O	O

PLAN	PLAN	NN	B-NP	B-protein
:	:	:	O	I-protein
1	1	LS	B-LST	I-protein
.	.	.	O	O

Cardiovascular	Cardiovascular	NNP	B-NP	O
:	:	:	O	O
Ischemia	Ischemia	NNP	B-NP	O
.	.	.	O	O

Because	Because	IN	B-PP	O
of	of	IN	I-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
new	new	JJ	I-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
ruled	rule	VBN	I-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
MI	MI	NN	B-NP	O
shortly	shortly	RB	B-ADVP	O
after	after	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Serial	Serial	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
and	and	CC	I-NP	O
EKGs	EKG	NNS	I-NP	B-protein
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
usual	usual	JJ	I-NP	O
cardiac	cardiac	JJ	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
her	her	PRP$	B-NP	O
stay	stay	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
aspirin	aspirin	NN	I-NP	O
,	,	,	O	O
beta-blocker	beta-blocker	NN	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
statin	statin	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
the	the	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
gone	go	VBN	I-VP	O
on	on	IN	B-PP	O
arrival	arrival	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ED	ED	NNP	I-NP	O
.	.	.	O	O

Throughout	Throughout	IN	B-PP	O
the	the	DT	B-NP	O
three	three	CD	I-NP	O
months	month	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
stay	stay	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
experience	experience	VB	I-VP	O
similar	similar	JJ	B-NP	O
burning	burning	NN	I-NP	O
,	,	,	O	O
substernal	substernal	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

EKGs	EKG	NNS	B-NP	B-protein
and	and	CC	I-NP	O
enzymes	enzyme	NNS	I-NP	B-protein
sent	send	VBN	B-VP	O
during	during	IN	B-PP	O
these	these	DT	B-NP	O
episodes	episode	NNS	I-NP	O
were	be	VBD	B-VP	O
always	always	RB	B-ADJP	O
negative	negative	JJ	I-ADJP	O
for	for	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
GERD	GERD	NNP	B-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
it	it	PRP	B-NP	O
often	often	RB	B-ADVP	O
responded	respond	VBD	B-VP	O
to	to	TO	B-PP	O
Maalox	Maalox	NNP	B-NP	O
,	,	,	O	O
benzo	benzo	NN	B-NP	O
,	,	,	O	O
lidocaine	lidocaine	NN	B-NP	O
and/or	and/or	CC	I-NP	O
food	food	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Pump	Pump	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
primary	primary	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
of	of	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
likely	likely	RB	B-ADJP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
fluid	fluid	NN	B-NP	O
overload	overload	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NNP	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
medicine	medicine	NN	I-NP	O
floor	floor	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
on	on	IN	B-PP	O
10/22/06	10/22/06	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
experienced	experience	VBD	B-VP	O
somnolence	somnolence	NN	B-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
respiratory	respiratory	JJ	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
desaturations	desaturation	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
opioid	opioid	JJ	B-NP	O
administration	administration	NN	I-NP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
responded	respond	VBD	B-VP	O
partially	partially	RB	B-ADVP	O
to	to	TO	B-PP	O
Narcan	Narcan	NNP	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
CCU	CCU	NN	I-NP	O
for	for	IN	B-PP	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
for	for	IN	B-PP	O
increased	increase	VBN	B-NP	O
monitoring	monitoring	NN	I-NP	O
and	and	CC	I-NP	O
continuation	continuation	NN	I-NP	O
of	of	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
goal	goal	NN	I-NP	O
of	of	IN	B-PP	O
negative	negative	JJ	B-NP	O
2	2	CD	I-NP	O
liters	liter	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
transitioned	transitione	VBN	I-VP	O
off	off	RP	B-PRT	O
methadone	methadone	NN	B-NP	O
and	and	CC	B-PP	O
on	on	IN	B-PP	O
to	to	TO	B-PP	O
oxycodone	oxycodone	NN	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
BiPAP	BiPAP	NN	B-NP	B-protein
and	and	CC	O	O
given	give	VBN	B-NP	O
albuterol	albuterol	NN	I-NP	O
and	and	CC	I-NP	O
DuoNeb	DuoNeb	NN	I-NP	O
inhalers	inhaler	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
passed	pass	VBD	B-VP	O
through	through	IN	B-PP	O
this	this	DT	B-NP	O
acute	acute	JJ	I-NP	O
decompensation	decompensation	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
complications	complication	NNS	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
E	E	NN	B-NP	O
on	on	IN	B-PP	O
7/7/06	7/7/06	CD	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
transitioned	transitione	VBN	I-VP	O
to	to	TO	I-VP	O
p.o.	p.o.	VB	I-VP	O
Lasix	Lasix	NNP	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
goal	goal	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
to	to	TO	I-NP	O
1.5	1.5	CD	I-NP	O
liters	liter	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
.	.	.	O	O

IV	IV	CD	B-NP	O
Lasix	Lasix	NNP	I-NP	O
were	be	VBD	B-VP	O
administered	administer	VBN	I-VP	O
p.r.n.	p.r.n.	NN	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath/physical	breath/physical	JJ	B-NP	O
exam	exam	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
fluid	fluid	NN	B-NP	O
overload	overload	NN	I-NP	O
.	.	.	O	O

One	One	CD	B-NP	O
week	week	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-VP	O
transfer	transfer	VB	I-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
transitioned	transitione	VBN	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NNP	I-NP	O
as	as	IN	B-PP	O
her	her	PRP$	B-NP	O
daily	daily	JJ	I-NP	O
output	output	NN	I-NP	O
had	have	VBD	B-VP	O
slowed	slow	VBN	I-VP	O
on	on	IN	B-PP	O
p.o.	p.o.	FW	B-NP	O
Lasix	Lasix	NNP	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
make	make	VB	I-VP	O
TBB	TBB	NN	B-NP	O
goals	goal	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
transfer	transfer	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
shows	show	VBZ	B-VP	O
signs	sign	NNS	B-NP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	O
overload	overload	NN	I-NP	O
,	,	,	O	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
BiPAP	BiPAP	NN	I-NP	O
requirement	requirement	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
relatively	relatively	RB	B-ADVP	O
while	while	IN	B-SBAR	O
pulmonary	pulmonary	JJ	B-NP	O
compensation	compensation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
dry	dry	JJ	I-NP	O
weight	weight	NN	I-NP	O
is	be	VBZ	B-VP	O
about	about	RB	B-NP	O
200	200	CD	I-NP	O
pounds	pound	NNS	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Rhythm	Rhythm	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
afib	afib	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
rate	rate	NN	B-NP	O
controlled	control	VBN	B-VP	O
with	with	IN	B-PP	O
Lopressor	Lopressor	NN	B-NP	B-protein
and	and	CC	I-NP	O
verapamil	verapamil	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
anticoagulated	anticoagulate	VBN	I-VP	O
for	for	IN	B-PP	O
both	both	DT	O	O
her	her	PRP$	B-NP	O
afib	afib	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
recent	recent	JJ	I-NP	O
PE	PE	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
INR	INR	NN	I-NP	O
goal	goal	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
to	to	TO	B-PP	O
3	3	CD	B-NP	O
.	.	.	O	O

Rate	Rate	NN	B-NP	O
control	control	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
and	and	CC	I-NP	O
calcium	calcium	NN	I-NP	O
channel	channel	NN	I-NP	O
blocker	blocker	NN	I-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
the	the	DT	B-NP	O
stay	stay	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
is	be	VBZ	B-VP	O
often	often	RB	B-ADVP	O
slightly	slightly	RB	B-ADJP	O
faster	fast	JJR	I-ADJP	O
than	than	IN	B-PP	O
goal	goal	NN	B-NP	O
ranging	range	VBG	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
90s	90s	CD	I-NP	B-DNA
to	to	TO	B-PP	I-DNA
110s	110s	CD	B-NP	I-DNA
.	.	.	O	O

Further	Further	JJ	B-NP	O
rate	rate	NN	I-NP	O
control	control	NN	I-NP	O
is	be	VBZ	B-VP	O
limited	limit	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
BP	BP	NN	I-NP	O
with	with	IN	B-PP	O
systolics	systolic	NNS	B-NP	O
often	often	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
90s	90s	CD	I-NP	B-DNA
to	to	TO	B-PP	I-DNA
100s	100s	CD	B-NP	I-DNA
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
begun	begin	VBN	I-VP	O
on	on	IN	B-PP	O
verapamil	verapamil	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
down	down	RB	B-ADVP	O
.	.	.	O	O

On	On	IN	B-PP	O
transfer	transfer	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
verapamil	verapamil	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
and	and	CC	O	O
atenolol	atenolol	NN	B-NP	O
70	70	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
issues	issue	NNS	I-NP	O
as	as	IN	B-SBAR	O
described	describe	VBN	B-VP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
PE	PE	NN	B-NP	O
and	and	CC	I-NP	O
COPD/asthma	COPD/asthma	NN	I-NP	O
.	.	.	O	O

Post	Post	NNP	B-NP	O
MICU	MICU	NNP	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
4	4	CD	B-NP	O
to	to	TO	I-NP	O
5	5	CD	I-NP	O
liters	liter	NNS	I-NP	O
oxygen	oxygen	NN	I-NP	O
by	by	IN	B-PP	O
nasal	nasal	JJ	B-NP	O
cannula	cannula	NN	I-NP	O
and	and	CC	B-PP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
with	with	IN	B-PP	O
BiPAP	BiPAP	NN	B-NP	B-protein
at	at	IN	B-PP	O
nighttime	nighttime	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
O2	O2	NN	I-NP	O
requirement	requirement	NN	I-NP	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
until	until	IN	B-PP	O
transfer	transfer	NN	B-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
requiring	require	VBG	B-VP	O
albuterol	albuterol	NN	B-NP	O
nebs	neb	NNS	I-NP	O
p.r.n.	p.r.n.	FW	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
kept	keep	VBN	I-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
for	for	IN	B-PP	O
PE	PE	NN	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
INR	INR	NN	I-NP	O
goal	goal	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
to	to	TO	B-PP	O
3	3	CD	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
baseline	baseline	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
0.8	0.8	CD	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
ARF	ARF	NN	B-NP	B-protein
felt	feel	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
CHF/volume	CHF/volume	NN	B-NP	O
overload	overload	NN	I-NP	O
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
poor	poor	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
output	output	NN	I-NP	O
,	,	,	O	O
decreasing	decrease	VBG	B-VP	O
perfusion	perfusion	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
kidneys	kidney	NNS	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
renal	renal	JJ	I-NP	O
function	function	NN	I-NP	O
improved	improve	VBD	B-VP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
stay	stay	NN	I-NP	O
until	until	IN	B-PP	O
10/24/06	10/24/06	CD	B-NP	O
when	when	WRB	B-ADVP	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
rise	rise	VB	I-VP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
combination	combination	NN	I-NP	O
over	over	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
prerenal	prerenal	JJ	I-NP	O
state	state	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
medication	medication	NN	I-NP	O
changes	change	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
made	make	VBN	I-VP	O
near	near	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
except	except	IN	B-PP	O
for	for	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
p.o.	p.o.	NN	I-NP	O
to	to	TO	B-PP	O
IV	IV	CD	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
creatinine	creatinine	NN	B-NP	O
bump	bump	NN	I-NP	O
,	,	,	O	O
Lasix	Lasix	NN	B-NP	O
and	and	CC	I-NP	O
spironolactone	spironolactone	NN	I-NP	O
were	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
on	on	IN	B-PP	O
10/12/06	10/12/06	CD	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
10/25/06	10/25/06	CD	B-NP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
20	20	CD	I-NP	O
IV	IV	CD	I-NP	O
daily	daily	NN	I-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
because	because	RB	B-PP	O
of	of	IN	I-PP	O
an	an	DT	B-NP	O
improving	improve	VBG	I-NP	O
creatinine	creatinine	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
again	again	RB	B-VP	O
held	hold	VBN	I-VP	O
when	when	WRB	B-ADVP	O
creatinine	creatinine	NN	B-NP	O
returned	return	VBD	B-VP	O
as	as	IN	B-PP	O
1.5	1.5	CD	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
transfer	transfer	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
not	not	RB	O	O
on	on	IN	B-PP	O
Lasix	Lasix	NN	B-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
creatinine	creatinine	NN	B-NP	B-protein
bumps/ARF	bumps/ARF	NN	I-NP	I-protein
.	.	.	O	O

We	We	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
hydrate	hydrate	VB	I-VP	O
but	but	CC	I-VP	O
monitor	monitor	VB	I-VP	O
creatinine	creatinine	NN	B-NP	O
and	and	CC	O	O
continue	continue	VB	B-VP	O
diuresis	diuresis	NN	B-NP	O
when	when	WRB	B-ADVP	O
able	able	JJ	B-ADJP	O
.	.	.	O	O

Likely	Likely	RB	B-NP	O
prerenal	prerenal	JJ	I-NP	O
secondary	secondary	JJ	I-NP	O
to	to	TO	B-PP	O
intravascular	intravascular	JJ	B-NP	O
depletion	depletion	NN	I-NP	O
caused	cause	VBN	B-VP	O
by	by	IN	B-PP	O
liver	liver	NN	B-NP	O
cirrhosis	cirrhosis	NN	I-NP	O
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
poor	poor	JJ	B-NP	O
intravascular	intravascular	JJ	I-NP	O
albumin/osmotic	albumin/osmotic	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
discontinuing	discontinue	VBG	B-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
and	and	CC	O	O
poor	poor	JJ	B-NP	O
renal	renal	JJ	I-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
become	become	VB	I-VP	O
hyperkalemic	hyperkalemic	JJ	B-NP	O
x2	x2	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
week	week	NN	I-NP	O
of	of	IN	B-PP	O
transfer	transfer	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
initially	initially	RB	I-VP	O
respond	respond	VB	I-VP	O
to	to	TO	B-PP	O
Kayexalate	Kayexalate	NN	B-NP	O
and	and	CC	I-NP	O
lactulose	lactulose	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
bowel	bowel	NN	I-NP	O
movement	movement	NN	I-NP	O
likely	likely	RB	B-ADJP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
opioid	opioid	JJ	B-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
respond	respond	VB	I-VP	O
to	to	TO	B-PP	O
insulins	insulin	NNS	B-NP	B-protein
and	and	CC	I-NP	O
D50	D50	NN	I-NP	B-protein
.	.	.	O	O

On	On	IN	B-PP	O
5/30/06	5/30/06	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
again	again	RB	B-ADVP	O
had	have	VBD	B-VP	O
the	the	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
potassium	potassium	NN	I-NP	O
to	to	TO	B-PP	O
5.5	5.5	CD	B-NP	O
,	,	,	O	O
Kayexalate	Kayexalate	NNP	B-NP	O
and	and	CC	O	O
lactulose	lactulose	NN	B-NP	B-protein
x2	x2	NN	I-NP	I-protein
,	,	,	O	O
produced	produce	VBD	B-VP	O
two	two	CD	B-NP	O
bowel	bowel	NN	I-NP	O
movements	movement	NNS	I-NP	O
lowering	lower	VBG	B-VP	O
her	her	PRP$	B-NP	O
K	K	NN	I-NP	O
appropriately	appropriately	RB	B-ADVP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
During	During	IN	B-PP	O
the	the	DT	B-NP	O
stay	stay	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
for	for	IN	B-PP	O
UTI	UTI	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
three-day	three-day	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
.	.	.	O	O

Upon	Upon	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
known	know	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
vascular	vascular	JJ	B-NP	O
ectasias	ectasia	NNS	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
still	still	RB	B-ADVP	O
guaiac	guaiac	JJ	B-ADJP	O
positive	positive	JJ	B-ADJP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
stay	stay	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
active	active	JJ	I-NP	O
bleeding	bleeding	NN	I-NP	O
.	.	.	O	O

Complicating	Complicate	VBG	B-VP	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
need	need	NN	I-NP	O
for	for	IN	B-PP	O
anticoagulation	anticoagulation	NN	B-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
recent	recent	JJ	B-NP	O
PE	PE	NN	I-NP	O
and	and	CC	I-NP	O
afib	afib	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
the	the	DT	B-NP	O
cause	cause	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP	B-NP	O
slowly	slowly	RB	B-VP	O
dropping	drop	VBG	I-VP	O
hematocrit	hematocrit	NN	B-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
required	require	VBD	B-VP	O
occasional	occasional	JJ	B-NP	O
weekly	weekly	JJ	I-NP	O
transfusions	transfusion	NNS	I-NP	O
of	of	IN	B-PP	O
packed	packed	JJ	B-NP	B-cell_type
red	red	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
PPI	PPI	NN	I-NP	B-protein
b.i.d.	b.i.d.	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
cirrhosis	cirrhosis	NN	B-NP	O
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
poor	poor	JJ	B-NP	O
synthetic	synthetic	JJ	I-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
poor	poor	JJ	B-NP	O
intravascular	intravascular	JJ	I-NP	O
osmotic	osmotic	JJ	I-NP	O
pool	pool	NN	I-NP	O
contributing	contribute	VBG	B-VP	O
to	to	TO	B-PP	O
fluid	fluid	NN	B-NP	O
overload	overload	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
As	As	IN	B-PP	O
above	above	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
required	require	VBD	B-VP	O
several	several	JJ	B-NP	O
transfusions	transfusion	NNS	I-NP	O
of	of	IN	B-PP	O
TIBCs	TIBC	NNS	B-NP	B-cell_type
,	,	,	O	O
although	although	IN	B-SBAR	O
no	no	DT	B-NP	O
more	more	JJR	I-NP	O
than	than	IN	I-ADVP	O
once	once	RB	I-ADVP	O
every	every	DT	B-NP	O
one	one	CD	I-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

Felt	Felt	NN	B-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-VP	O
slow	slow	VB	I-VP	O
GI	GI	NN	B-NP	O
losses	loss	NNS	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Endocrine	Endocrine	JJ	B-ADJP	O
:	:	:	O	O
During	During	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
stay	stay	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
basal	basal	JJ	I-NP	O
Lantus	Lantus	NNP	I-NP	O
with	with	IN	B-PP	O
Aspart	Aspart	NNP	B-NP	O
coverage	coverage	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
up	up	RP	B-PRT	O
to	to	TO	B-VP	O
achieve	achieve	VB	I-VP	O
good	good	JJ	B-NP	O
glycemic	glycemic	JJ	I-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
Lantus	Lantus	NNP	B-NP	O
42	42	CD	I-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
and	and	CC	I-NP	O
Aspart	Aspart	NN	I-NP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
a.c.	a.c.	NN	I-NP	O
/	/	SYM	B-NP	O
h.s.	h.s.	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
Aspart	Aspart	NNP	I-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
achieved	achieve	VBD	B-VP	O
fingerstick	fingerstick	NN	B-NP	O
glucoses	glucose	NNS	I-NP	O
of	of	IN	B-PP	O
120s	120s	CD	B-NP	B-DNA
to	to	TO	B-PP	I-DNA
160s	160s	CD	B-NP	I-DNA
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Psych	Psych	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
addiction	addiction	NN	B-NP	O
and	and	CC	O	O
came	come	VBD	B-VP	O
to	to	TO	B-PP	O
SMH	SMH	NN	B-NP	B-protein
on	on	IN	B-PP	O
methadone	methadone	NN	B-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
stay	stay	NN	I-NP	O
,	,	,	O	O
methadone	methadone	NN	B-NP	O
was	be	VBD	B-VP	O
tapered	taper	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
transitioned	transitione	VBN	B-VP	O
to	to	TO	B-PP	O
oxycodone	oxycodone	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
often	often	RB	B-ADVP	O
complained	complain	VBD	B-VP	O
of	of	IN	B-PP	O
back	back	JJ	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
burning	burn	VBG	B-VP	O
foot	foot	NN	B-NP	O
pain	pain	NN	I-NP	O
felt	feel	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
neuropathy	neuropathy	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
relieved	relieve	VBN	I-VP	O
by	by	IN	B-PP	O
opioids	opioid	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
often	often	RB	B-ADVP	O
refusing	refuse	VBG	B-VP	O
NSAIDs	NSAID	NNS	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
transfer	transfer	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
oxycodone	oxycodone	NN	B-NP	O
5	5	CD	I-NP	O
to	to	TO	I-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
6	6	CD	I-NP	O
h.	h.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
often	often	RB	B-ADVP	O
taking	take	VBG	B-VP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
x4	x4	CD	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
complaints	complaint	NNS	B-NP	O
of	of	IN	B-PP	O
anxiety	anxiety	NN	B-NP	O
and	and	CC	I-NP	O
insomnia	insomnia	NN	I-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
0.5	0.5	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
Ativan	Ativan	NNP	B-NP	O
achieved	achieve	VBD	B-VP	O
good	good	JJ	B-NP	O
resolution	resolution	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
transfer	transfer	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
on	on	IN	B-PP	O
standing	stand	VBG	B-VP	O
Ativan	Ativan	NNP	B-NP	O
just	just	RB	B-VP	O
requiring	require	VBG	I-VP	O
occasional	occasional	JJ	B-NP	O
one-time	one-time	JJ	I-NP	O
orders	order	NNS	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

Neurontin	Neurontin	NN	B-NP	B-protein
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
titrated	titrate	VBN	I-VP	O
up	up	RP	B-PRT	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

Finally	Finally	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
nortriptyline	nortriptyline	NN	B-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
effect	effect	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAM	EXAM	NN	I-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
x3	x3	NN	B-NP	O
sitting	sit	VBG	B-VP	O
up	up	RP	B-PRT	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
chair	chair	NN	I-NP	O
,	,	,	O	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
walk	walk	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
bathroom	bathroom	NN	I-NP	O
unassisted	unassisted	JJ	B-ADJP	O
.	.	.	O	O

Off	Off	NN	B-NP	B-protein
of	of	IN	B-PP	O
O2	O2	NN	B-NP	B-protein
,	,	,	O	O
although	although	IN	B-SBAR	O
does	do	VBZ	B-VP	O
experience	experience	VB	I-VP	O
mild	mild	JJ	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

Pupils	Pupil	NNS	B-NP	O
equal	equal	JJ	I-NP	O
,	,	,	I-NP	O
round	round	JJ	I-NP	O
and	and	CC	I-NP	O
reactive	reactive	JJ	I-NP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
and	and	CC	I-NP	O
accommodation	accommodation	NN	I-NP	O
.	.	.	O	O

Extraocular	Extraocular	JJ	B-NP	O
movements	movement	NNS	I-NP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
,	,	,	O	O
irregularly	irregularly	RB	B-ADJP	O
irregular	irregular	JJ	I-ADJP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	I-NP	O
gallops	gallop	NNS	I-NP	O
or	or	CC	I-NP	O
rubs	rub	NNS	I-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-NP	O
,	,	,	I-NP	O
faint	faint	JJ	I-NP	O
bibasilar	bibasilar	JJ	I-NP	O
crackles	crackle	NNS	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
wheezes	wheeze	NNS	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
,	,	,	O	O
distended	distended	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
nontender	nontender	JJ	I-ADJP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
,	,	,	O	O
warm	warm	NN	B-NP	O
,	,	,	O	O
well	well	RB	B-VP	O
perfused	perfuse	VBN	I-VP	O
with	with	IN	B-PP	O
dressings	dressing	NNS	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
lower	low	JJR	I-NP	O
calf	calf	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
clean	clean	JJ	B-ADJP	O
,	,	,	I-ADJP	O
dry	dry	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
intact	intact	JJ	I-ADJP	O
.	.	.	O	O

Neuro	Neuro	RB	B-ADVP	O
,	,	,	O	O
cranial	cranial	JJ	B-NP	O
nerves	nerve	NNS	I-NP	O
II	II	CD	B-NP	O
through	through	IN	B-PP	O
XII	XII	CD	B-NP	B-DNA
grossly	grossly	RB	I-NP	O
intact	intact	JJ	I-NP	O
.	.	.	O	O

Strength	Strength	NN	B-NP	O
5/5	5/5	CD	I-NP	O
throughout	throughout	IN	B-ADVP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
sensory	sensory	JJ	I-NP	O
deficits	deficit	NNS	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

DuoNeb	DuoNeb	NNP	B-NP	O
q.	q.	NN	I-NP	O
6	6	CD	I-NP	O
h.	h.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath/wheezing	breath/wheeze	VBG	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Aquaphor	Aquaphor	NN	B-NP	O
topical	topical	JJ	I-NP	O
daily	daily	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Atenolol	Atenolol	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

BuSpar	BuSpar	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
5	5	CD	I-NP	O
.	.	.	O	O

Digoxin	Digoxin	NN	B-NP	O
0.0625	0.0625	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Duloxetine	Duloxetine	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Nexium	Nexium	NN	B-NP	B-protein
40	40	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
b.i.d.	b.i.d.	NN	I-NP	I-protein
8	8	CD	I-NP	I-protein
.	.	.	O	O

Neurontin	Neurontin	NN	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
and	and	CC	O	O
600	600	CD	B-NP	O
mg	mg	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Ibuprofen	Ibuprofen	NN	B-NP	B-protein
100	100	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
q.	q.	NN	I-NP	I-protein
6	6	CD	I-NP	I-protein
h.	h.	NN	I-NP	I-protein
p.r.n.	p.r.n.	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Insulin	Insulin	NNP	B-NP	O
Aspart	Aspart	NNP	I-NP	O
10	10	CD	I-NP	O
units	unit	NNS	I-NP	O
SC	SC	NNP	I-NP	O
,	,	,	O	O
a.c.	a.c.	RB	B-ADVP	O
plus	plus	CC	B-PP	O
sliding	slide	VBG	B-NP	O
scale	scale	NN	I-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Lantus	Lantus	NNP	B-NP	O
42	42	CD	I-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Lactulose	Lactulose	RB	B-NP	O
30	30	CD	I-NP	O
mL	mL	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
13	13	CD	I-NP	O
.	.	.	O	O

Maalox	Maalox	NNP	B-NP	O
liquid	liquid	JJ	I-NP	O
maximum	maximum	JJ	I-NP	O
strength	strength	NN	I-NP	O
10	10	CD	I-NP	O
to	to	TO	I-NP	O
20	20	CD	I-NP	O
mL	mL	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
6	6	CD	I-NP	O
h.	h.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
upset	upset	NN	I-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Reglan	Reglan	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.i.d.	q.i.d.	FW	I-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
nausea	nausea	NN	I-NP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

Miconazole	Miconazole	NN	B-NP	O
nitrate	nitrate	NN	I-NP	O
2	2	CD	B-NP	O
%	%	NN	I-NP	O
powder	powder	NN	I-NP	O
topical	topical	JJ	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
16	16	CD	I-NP	O
.	.	.	O	O

Nortriptyline	Nortriptyline	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

17	17	CD	B-NP	O
.	.	.	O	O

Oxycodone	Oxycodone	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
q.	q.	NN	I-NP	I-protein
6	6	CD	I-NP	I-protein
h.	h.	NN	I-NP	I-protein
p.r.n.	p.r.n.	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

18	18	CD	B-NP	O
.	.	.	O	O

Seroquel	Seroquel	NN	B-NP	O
3000	3000	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
19	19	CD	I-NP	O
.	.	.	O	O

Sarna	Sarna	NNP	B-NP	O
topical	topical	JJ	B-ADJP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

20	20	CD	B-NP	O
.	.	.	O	O

Verapamil	Verapamil	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
21	21	CD	I-NP	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
3.5	3.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
TO-DO	TO-DO	NN	I-NP	O
PLAN	PLAN	NN	I-NP	O
:	:	:	O	O
To	To	TO	B-PP	O
accepting	accept	VBG	B-VP	O
MD.	MD.	NNP	B-NP	O
.	.	.	O	O

ACTIVE	ACTIVE	NN	B-NP	O
ISSUES	ISSUES	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Fluid	Fluid	NN	B-NP	O
balance	balance	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
still	still	RB	B-ADVP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
weight	weight	NN	I-NP	O
at	at	IN	B-PP	O
200	200	CD	B-NP	O
pounds	pound	NNS	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
intravascularly	intravascularly	RB	B-ADJP	O
dry	dry	JJ	I-ADJP	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
cirrhosis	cirrhosis	NN	B-NP	O
.	.	.	O	O

Discharge	Discharge	NN	B-NP	O
diuresis	diuresis	NN	I-NP	O
was	be	VBD	B-VP	O
limited	limit	VBN	I-VP	O
by	by	IN	B-PP	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
likely	likely	RB	B-ADJP	O
prerenal	prerenal	JJ	I-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
received	receive	VBN	I-VP	B-cell_type
packed	pack	VBN	I-VP	I-cell_type
red	red	JJ	B-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
for	for	IN	B-PP	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
hematocrit	hematocrit	NN	I-NP	O
and	and	CC	B-PP	O
for	for	IN	B-PP	O
colloid	colloid	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
resuscitation	resuscitation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
responds	respond	VBZ	B-VP	O
to	to	TO	B-PP	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
or	or	CC	I-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
Please	Please	NNP	B-NP	O
continue	continue	VB	B-VP	O
when	when	WRB	B-ADVP	O
renal	renal	JJ	B-NP	O
function	function	NN	I-NP	O
improves	improve	VBZ	B-VP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Electrolytes	Electrolyte	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
hyperkalemic	hyperkalemic	JJ	B-ADJP	O
twice	twice	RB	B-ADVP	O
this	this	DT	B-NP	O
week	week	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
poor	poor	JJ	B-NP	O
urine	urine	NN	I-NP	O
output	output	NN	I-NP	O
and	and	CC	O	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
responds	respond	VBZ	B-VP	O
to	to	TO	I-VP	O
lactulose	lactulose	VB	I-VP	O
and	and	CC	O	O
K	K	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
EKG	EKG	NN	I-NP	B-protein
was	be	VBD	B-VP	O
unchanged	unchanged	JJ	B-ADJP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

GI	GI	NN	B-NP	O
bleed	bleed	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
vascular	vascular	JJ	B-NP	O
ectasias	ectasia	NNS	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
GI	GI	NN	I-NP	O
tract	tract	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
for	for	IN	B-PP	O
afib	afib	NN	B-NP	O
and	and	CC	I-NP	O
PE	PE	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
Nexium	Nexium	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
stools	stool	NNS	I-NP	O
are	be	VBP	B-VP	O
guaiac	guaiac	JJ	B-ADJP	O
positive	positive	JJ	I-ADJP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
slowly	slowly	RB	I-NP	O
dropping	drop	VBG	I-NP	O
crit	crit	NN	I-NP	O
,	,	,	O	O
might	might	MD	B-VP	O
be	be	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
slow	slow	JJ	I-NP	O
GI	GI	NN	I-NP	O
bleed	bleed	NN	I-NP	O
.	.	.	O	O

Transfused	Transfuse	VBN	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
goal	goal	NN	I-NP	O
hematocrit	hematocrit	NN	I-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
25	25	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
INR	INR	NN	I-NP	O
goal	goal	NN	I-NP	O
is	be	VBZ	B-VP	O
2	2	CD	B-NP	O
to	to	TO	B-PP	O
3	3	CD	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Physical	Physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
has	have	VBZ	B-VP	O
worked	work	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
get	get	VB	I-VP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
bed	bed	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
bathroom	bathroom	NN	I-NP	O
by	by	IN	B-PP	O
herself	herself	PRP	B-NP	O
,	,	,	O	O
though	though	IN	B-SBAR	O
slowly	slowly	RB	B-ADVP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
BiPAP	BiPAP	NN	B-NP	B-protein
at	at	IN	B-PP	O
night	night	NN	B-NP	O
,	,	,	O	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
secure	secure	VB	I-VP	O
facemask	facemask	NN	B-NP	O
on	on	IN	B-PP	O
by	by	IN	B-PP	O
herself	herself	PRP	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
4	4	CD	B-NP	O
to	to	TO	I-NP	O
5	5	CD	I-NP	O
liters	liter	NNS	I-NP	O
of	of	IN	B-PP	O
nasal	nasal	JJ	B-NP	O
cannula	cannula	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
daytime	daytime	NN	I-NP	O
,	,	,	O	O
though	though	IN	B-SBAR	O
she	she	PRP	B-NP	O
often	often	RB	B-ADVP	O
takes	take	VBZ	B-VP	O
,	,	,	O	O
but	but	CC	O	O
removes	remove	VBZ	B-VP	O
the	the	DT	B-NP	O
oxygen	oxygen	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Psych/Pain	Psych/Pain	NN	B-NP	B-protein
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
oxycodone	oxycodone	NN	B-NP	O
at	at	IN	B-PP	O
minimum	minimum	NN	B-NP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
received	receive	VBN	I-VP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
x3	x3	CD	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
now	now	RB	B-ADVP	O
at	at	IN	B-PP	O
4	4	CD	B-NP	O
to	to	TO	B-PP	O
5	5	CD	B-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
full	full	JJ	B-NP	O
code	code	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
7-9071226	7-9071226	CD	B-NP	O
CSSten	CSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Andre	Andre	NNP	B-NP	O
Mccammack	Mccammack	NNP	I-NP	O
NP	NP	NNP	I-NP	O
Ham	Ham	NNP	I-NP	O
Rota	Rota	NNP	I-NP	O
Center	Center	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Milan	Milan	NNP	B-NP	O
Kommer	Kommer	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
Us	Us	NNP	I-NP	O
Ward	Ward	NNP	I-NP	O
Norf	Norf	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Jamaal	Jamaal	NNP	B-NP	O
Billingham	Billingham	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
Rill	Rill	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
PAVLOCK	PAVLOCK	NNP	B-NP	O
,	,	,	O	O
JAKE	JAKE	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BRADLY	BRADLY	NNP	B-NP	O
DAVERS	DAVERS	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
GN22	GN22	NNP	I-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
6953596	6953596	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
10/29/06	10/29/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
10/29/06	10/29/06	CD	B-NP	O

